News

renal stenting

The use of renal stenting in combination with medication-based therapy to treat hypertension showed no improvement in patient outcomes over the use of medications alone in treating hypertension....

clinical trial study stents cath lab mguard inspiremd

InspireMD Inc., a developer of embolic protection stents, announced 12-month results from the MGuard for Acute ST Elevation Reperfusion (MASTER) ...

stents cath lab biotronik pk papyrus

Biotronik announced that the PK Papyrus covered coronary stent system has received CE mark for the treatment of...

stents peripheral clinical triady study S.M.A.R.T. nitinol stent cordis

Researchers at Saint Luke’s Mid America Heart Institute led a study that showed marked, long-term improvement...

stents bioresorbable cath lab intravascular imaging clinical trial study abbott

The Cardiovascular Research Foundation (CRF) and the Uppsala Clinical Research Center (UCR) of Uppsala, Sweden announced the initiation of the Providing Regional Observations to Study Predictors...

robotic systems cath lab stents navigation systems corindus corpath one

Corindus Vascular Robotics, a provider of precision medical robotics, announced the launch of its CorPath One Stent Program.

A new study demonstrated that some patients may not need to receive prolonged anti-clotting therapy after drug-...

tryton stent, bifurcation stenting

clinical trial designed to measure the effectiveness of using a dedicated side branch-covering bare metal...

Promus Element, Boston Scientific, Promus Element stent, drug-eluting stent

In the first head-to-head randomized controlled trial of third-generation durable-polymer drug-eluting stents for the treatment of coronary artery disease in an all-comers patient population, the...

A new study showed that a conservative approach to revascularization for patients with intermediate coronary...

stents biforcation clinical trial study cath lab tryton tct side branch

Tryton Medical Inc., a developer of stents designed to treat bifurcation lesions, announced activities...

xience prime xpedition V antiplatelet stents eluting clinical trial study cath

Abbott announced it plans to initiate a randomized, controlled trial in the United States to evaluate the use...

stents bioresorbable fortitude amaranth

Amaranth Medical, a privately held medical device company, presented positive six-month angiographic results from its first-in-human study including patients undergoing percutaneous...

balloon catheters stents clinical trial study orbusneich scoreflex journal

OrbusNeich announced the publication of a study demonstrating that lesion preparation with the company’s...

biotronik orsiro stents drug-eluting cinical trial bioflow

Biotronik Japan announced enrollment of the first patient in the Bioflow-IV study, which aims to verify the efficacy...

stents drug eluting biosensors tct 2012 transcatheter biomatrix neoflex spectrum

Biosensors International’s expanded product portfolio offers physicians a broader range of treatment options to improve patient outcomes.

October 23, 2013 — Vascular Interventional Advances (VIVA) Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...